Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis
Clinical trial NCT04324918 · COMPLETED
Trial details
- NCT number
- NCT04324918
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-23
- Primary completion
- 2019-06-24
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.